Two hospitals use Varian RapidArc to treat brain metastases

Two cancer centers have carried out radiosurgery treatments for multiple brain metastases using new RapidArc radiotherapy technology from Varian Medical Systems.

The MIMA Cancer Center in Melbourne, Fla., and the VU University Medical Center in Amsterdam, Netherlands, have treated brain metastases with the technology, according to the Palo Alto, Calif.-based Varian.

RapidArc, which targets treatment beams at tumors while rotating continuously around the patient, makes it possible to complete stereotactic radiosurgery sessions faster than conventional techniques that use stationary beams, the company said.

Around the web

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease. 

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care.